CNCE
Concert Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Roger D. Tung
IPO Date
2014-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Concert Pharmaceuticals, Inc.
CEO
Roger D. Tung
IPO Date
2014-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 49,699 |
| $0.00 |
| 6 Mar 2023 | Becker Marc A. | Chief Financial Officer | D-Return | Disposed | 17,900 | $0.00 |
| 6 Mar 2023 | Becker Marc A. | Chief Financial Officer | D-Return | Disposed | 100,000 | $27.59 |
| 6 Mar 2023 | Becker Marc A. | Chief Financial Officer | D-Return | Disposed | 110,000 | $13.93 |
| 6 Mar 2023 | Becker Marc A. | Chief Financial Officer | D-Return | Disposed | 42,430 | $10.87 |
| 6 Mar 2023 | Becker Marc A. | Chief Financial Officer | D-Return | Disposed | 51,850 | $13.07 |
| 6 Mar 2023 | Stuart Nancy | Chief Operating Officer | U-Tender | Disposed | 167,963 | $8.00 |
| 6 Mar 2023 | Stuart Nancy | Chief Operating Officer | D-Return | Disposed | 73,233 | $0.00 |
| 6 Mar 2023 | Stuart Nancy | Chief Operating Officer | D-Return | Disposed | 21,400 | $0.00 |